Self-Driving Lab

Telescope Innovations reported a 31.8% revenue surge to CAD $5.8 million in FY2025, alongside increased R&D spending. Key developments include progress on a Pfizer Self-Driving Lab project, record sales for DirectInject-LC with European and Asian market entries, and initial shipments of battery-grade lithium sulfide produced via a proprietary method. The company is transitioning from development to commercialization, aiming to capitalize on demand for intelligent, automated chemistry solutions.